Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong · Delayed Price · Currency is HKD 4.620
-0.425 (-8.42%)
Nov 3, 2026, 3:59 PM HKT
HKG:2566 Market Cap
HKG:2566 has a market cap or net worth of 1.11 billion as of November 2, 2026. It is the 22,245th most valuable company in the world and the 1,047th biggest in Hong Kong. Its market cap has decreased by 46.58% in one year.
Market Cap
1.11B
Enterprise Value
564.00M
Revenue
1.50B
Global Rank
Country Rank
#1,047 Hong Kong
PE Ratio
6.99
ChartMarket Cap Chart
Since November 28, 2024, HKG:2566's market cap has decreased from 1.88B to 1.11B, a decrease of -40.93%. That is a compound annual growth rate of -23.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 1.11B | -40.23% |
| Dec 31, 2025 | 1.86B | 14.55% |
| Dec 31, 2024 | 1.62B | -13.73% |
| Nov 28, 2024 | 1.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 1.50B |
| Beijing Biostar Pharmaceuticals | 1.44B |
| PegBio | 1.44B |
| SinoMab BioScience | 1.41B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.24B |
| Cloudbreak Pharma | 1.10B |
| TYK Medicines | 1.10B |
| Zhaoke Ophthalmology | 1.09B |